Skip to main content

Nivolumab for Hodgkin's Lymphoma User Reviews

Brand names: Opdivo

Rating: 9.0

Nivolumab has an average rating of 9.0 out of 10 from a total of 3 reviews for the treatment of hodgkin's lymphoma. 67% of reviewers reported a positive experience, while 0% reported a negative experience.

10
67%
9
0%
8
0%
7
33%
6
0%
5
0%
4
0%
3
0%
2
0%
1
0%
  • Ter...
  • August 22, 2017

"I have both NHL and HL, have been on Opdivo since Feb 2017. I've had very little side effects, mostly a small rash. My hemoglobin went from 59 to 145. I feel great, and I'm preparing for a donor stem cell transplant in Sept 2017. I've had an autologous stem cell transplant and several different chemos."

10 / 10
Was this helpful?YesNo
1 Report
  • vim...
  • Taken for 1 to 6 months
  • April 28, 2025

"Fever just happened after taking the medication for 4 hours. Fever lasted for 2 days. Now back to normal."

7 / 10
Was this helpful?YesNo
0 Report
  • Ist...
  • Taken for 1 to 6 months
  • April 1, 2025

"Nivo AVD over 6 months of infusions resulted in a clear PET scan. Side effects were extreme fatigue and some gastrointestinal distress."

10 / 10
Was this helpful?YesNo
0 Report

Frequently asked questions

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

Learn more about Hodgkin's Lymphoma

Care guides

Symptoms and treatments